Chest radiographs in pregnancy

O’Connor, Sheila J.M.; Verma, H. K.; Grubnic, Sisa; Rayner, Charlotte F. J.

doi:10.1136/bmj.b4057

Cited by 3 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a recent case report, the fetal radiation doses during PET scan were as high as 11.8 mGy; CT scan added a further 10 mGy, suggesting that the use of PET/CT scan should be avoided in pregnancy [5•]. A single postero-anterior radiograph of the chest, with proper shielding, should be obtained to characterize the extent of mediastinal and pulmonary disease, because overall radiation exposure is much lower than the dose required to cause malformation during organogenesis [6]. Abdominal ultrasonography should be used to identify the extent and size of retroperitoneal nodal disease and provides sufficient detail for proper management [3].…”

Section: Diagnostic Approach To Hl During Pregnancymentioning

confidence: 99%

Hodgkin Lymphoma in Pregnancy

Bachanová

Connors

2013

Curr Hematol Malig Rep

View full text Add to dashboard Cite

The peak incidence of Hodgkin lymphoma (HL) coincides with reproductive years, and as many as 3 % of all HL patients present with concurrent pregnancy. The management of a pregnant patient with HL requires a multidisciplinary approach combining expertise in medical oncology, high-risk obstetrics, and neonatology, as well as effective communication with the patient and her family. The goal is to optimize the mother’s chance of a cure while allowing for delivery of a healthy child. A pregnant patient with HL should be staged by clinical examination and judicious use of non-radiation imaging such as ultrasound, balancing the need for accurate disease assessment with the need to minimize invasive procedures. The treatment strategy is individualized to the symptoms, lymphoma stage, gestational age and the patients’ wishes. Therapeutic options include treatment deferral or single-agent vinblastine with reservation of multi-agent chemotherapy until the second or third trimester for the small minority of patients with aggressive clinical presentation.

show abstract

Section: Diagnostic Approach To Hl During Pregnancymentioning

confidence: 99%